Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × niraparib × Clear all

Phase

Status

Completed 24 Active not recruiting 14 Terminated 9 Recruiting 4 Approved for marketing 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

OTHER 11 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 26 Cyclophosphamide 25 Cisplatin 24 Carboplatin 22 Bevacizumab 20 Nivolumab 19 pembrolizumab 18 Docetaxel 18 Rituximab 17 Fluorouracil 17 Dexamethasone 15 avelumab 14 Leucovorin 13 Gemcitabine 13 Capecitabine 11 fludarabine 10 Ipilimumab 10 venetoclax 9 atezolizumab 9 Radiotherapy 9 Cetuximab 9 ALT-803 9 130-nm albumin-bound paclitaxel 9 Pemetrexed 8 trametinib 7 Radiosurgery 7 Prednisone 7 Oxaliplatin 7 Lenalidomide 7 Bendamustine Hydrochloride 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04655183 2021-06-30

Study of M4344 in Combination With Niraparib

EMD Serono

Phase 1/2 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡